ARQQ vs QBTS Stock Comparison

Arqit Quantum and D-Wave Quantum Prices as of Oct 23, 2026 Peers: Industry group
ARQQ Arqit Quantum Inc.
$16.41 -27.2% 1M -58.0% 1Y
Market cap
$224.75M
P/E
–
Revenue (TTM)
—
Div. yield
–
Quantum Computing Technology
1 win
QBTS D-Wave Quantum Inc.
$11.66 -30.6% 1M -62.5% 1Y
Market cap
$4.27B
P/E
–
Revenue (TTM)
$12.43M
Div. yield
–
Quantum Computing Technology
3 wins

Head to Head

4 decided of 12

D-Wave Quantum leads on 3 of the 12 questions below (D-Wave Quantum 3, Arqit Quantum 1). Which ones matter depends on what you are buying for; a cheap multiple and slow growth often come together.

QuestionARQQQBTSLeader
Larger companyMarket capitalisation $224.75M $4.27B QBTS
Cheaper on earningsLower P/E, profitable companies only — -17.2x –
Cheaper on forward earningsLower price / next fiscal year consensus EPS — — –
Faster revenue growthRevenue growth, trailing twelve months — -44.2% –
More profitableNet margin, trailing twelve months — -2,001.6% –
Better return on capitalReturn on invested capital — -12.3% –
Less leveragedLower net debt / EBITDA — 3.2x –
Higher dividend yieldTrailing dividend yield 0.00% 0.00% –
Better 1-year returnPrice return, last 12 months -58.0% -62.5% ARQQ
Better 5-year returnAnnualised price return, 5 years -47.6%/yr +3.6%/yr QBTS
Less volatileAnnualised volatility, 1 year 111.5% 101.1% QBTS
Higher overall scoreMean of the five percentile scores vs peers — 32/100 –

Percentile Scorecard

ARQQQBTS

Each axis is the mean percentile of its metrics against the company's industry group. 100 is the best in the group, 50 the middle.

Scores by Axis

AxisARQQQBTS
Valuation – 18 #102 of 124
Growth – 11 #101 of 113
Profitability – 15 #94 of 110
Financial Health 84 #22 of 129 92 #11 of 129
Shareholder Returns – 27 #50 of 68
Overall – 32
  • ARQQ ranked among 137 companies in Infrastructure Software
  • QBTS ranked among 137 companies in Infrastructure Software

Price Performance

Price return, split-adjusted, before dividends. Click a name to hide or show it.

Returns

PeriodARQQQBTSSPY
1 month -27.2%-30.6% -1.0%
3 months -1.4%-28.2% +2.9%
6 months +12.9%-36.9% +6.4%
Year to date -25.0%-55.4% +11.4%
1 year -58.0%-62.5% +13.1%
3 years +49.2%+1,375.9% +79.4%
3 years, per year +14.3%+145.4% +21.5%
5 years -96.0%+19.1% +67.7%
5 years, per year -47.6%+3.6% +10.9%

Risk

MeasureARQQQBTSSPY
Volatility, 1Y 111.5%101.1% 12.7%
Downside volatility, 1Y 103.0%94.7% 12.7%
Beta vs S&P 500, 1Y 4.124.18 1.00
Return / volatility, 1Y -0.52-0.62 1.03
Max drawdown, 5Y -99.6%-96.7% -25.4%
From 52-week high -65.1%-68.5% -2.5%
52-week high $47.04$37.06 $779.14
52-week low $11.78$11.63 $631.97

Valuation History

Weekly multiples on trailing twelve-month fundamentals. Negative or extreme readings (a loss year, a collapsed denominator) are left out so the chart stays readable.

MultipleARQQQBTS
P/E now vs peer median —median 37.4x -17.4xmedian 37.4x
P/S now vs peer median —median 4.4x 349.1xmedian 4.4x
EV/EBITDA now vs peer median —median 35.0x -23.7xmedian 35.0x
P/FCF now vs peer median —median 27.2x -36.4xmedian 27.2x
P/B now vs peer median 8.8xmedian 3.4x 4.0xmedian 3.4x
PEG now vs peer median —median 1.27 11.69median 1.27

Financial History

Reported figures by fiscal period, placed on the calendar year (or quarter) each period ended in, so companies with different fiscal years line up.

Trailing twelve monthsARQQQBTS
Revenue – $12.43M
Gross profit – $7.98M
Operating income – -$170.58M
Net income – -$248.70M
Free cash flow – -$119.08M
R&D – $81.78M
EPS (diluted) – $-0.67
Cash & equivalents $28.86M $296.64M
Total debt – $138.75M
Shares (diluted) 13.79M 370.84M
Enterprise value $115.42M $1.41B

All Metrics

58 metrics · best in bold

Bold marks the best reading: the lowest positive value for multiples, leverage and payout, the highest for everything else. The bar under each value is its percentile against that company's own peers. Hover a value for its rank and the peer median.

Valuation

12 metrics
MetricARQQQBTS
P/E – -17.4x
P/FCF – -36.4x
P/Operating cash flow – -39.1x
P/S – 349.1x
P/B 8.8x 4.0x
P/Tangible book 9.5x 5.0x
EV/EBITDA – -23.7x
EV/EBIT – -22.4x
EV/Revenue – 308.0x
EV/FCF – -32.1x
EV/Operating cash flow – -34.5x
PEG (3Y EPS CAGR) – 11.69

Growth

14 metrics
MetricARQQQBTS
Revenue growth (1Y) – -44.2%
Revenue CAGR (3Y) – 19.0%
Gross profit growth (1Y) – -56.6%
Gross profit CAGR (3Y) – 31.6%
Operating income growth (1Y) – -116.9%
Operating income CAGR (3Y) – -27.8%
Net income growth (1Y) – 11.7%
Net income CAGR (3Y) – -45.9%
EPS growth (1Y) – 28.0%
EPS CAGR (3Y) – -1.5%
Operating cash flow growth (1Y) – -119.0%
Operating cash flow CAGR (3Y) – -28.1%
Free cash flow growth (1Y) – -124.4%
Free cash flow CAGR (3Y) – -30.9%

Profitability

14 metrics
MetricARQQQBTS
Gross margin – 64.2%
EBITDA margin – -1,297%
Operating margin – -1,373%
Pretax margin – -1,267%
Net margin – -2,002%
FCF margin – -958.4%
Operating cash flow margin – -892.4%
Return on equity – -11.7%
Return on assets – -10.9%
Return on invested capital – -12.3%
Return on capital employed – -14.8%
Asset turnover – 0.0x
Cash conversion (OCF / net income) – 0.4x
Stock comp / revenue – 250.5%

Financial Health

11 metrics
MetricARQQQBTS
Debt / assets – 3.0%
Debt / equity – 0.0x
Net debt / EBITDA – 3.2x
Debt / FCF – -0.3x
Liabilities / assets 21.3% 6.5%
Equity / assets 78.7% 93.5%
Interest coverage – -180.3x
Current ratio 4.9x 20.5x
Quick ratio 4.9x 20.1x
Cash ratio 4.4x 20.0x
Altman Z-score – 33.36

Shareholder Returns

7 metrics
MetricARQQQBTS
Dividend yield – –
Net buyback yield – -1.4%
Shareholder yield – -1.4%
Payout ratio (earnings) – –
Payout ratio (FCF) – –
Dividend growth (1Y) – –
Dividend CAGR (3Y) – –

Analyst Estimates

Solid lines are reported fiscal-year results; dashed lines are the consensus for the years ahead. Hover a year for the analysts' high and low, and how each result compared with its estimate.

ConsensusARQQQBTS
EPS, next fiscal year $-1.46FY2026 $-0.31FY2026
Revenue, next fiscal year $2.41MFY2026 $40.06MFY2026
Revenue growth, next FY +355.4%FY2026 +62.9%FY2026
Revenue growth, the year after +208.4% +112.2%

Institutional Ownership

13F filings, quarter ended Jun 30, 2026
HoldersARQQQBTS
Held by institutions 89.2% 53.1%
Institutions holding 65 549
Change in shares held, QoQ +205.7% +12.5%
Institutions buying 41 369
Institutions selling 11 100
Buyers to sellers 3.73 3.69

Return Correlation

Daily returns, last 12 months

1.00 means two stocks move in lockstep, 0 that they move independently. Pairs below about 0.5 diversify each other.

ARQQQBTS
ARQQ 1.00 0.67
QBTS 0.67 1.00

Add a Peer

Largest companies in the same industry

Related Comparisons

Frequently Asked Questions

Which is bigger, ARQQ and QBTS?

D-Wave Quantum (QBTS) is the largest by market capitalisation: Arqit Quantum (ARQQ) $224.75M, D-Wave Quantum (QBTS) $4.27B.

Which stock has performed better?

Over the past year Arqit Quantum (ARQQ) returned the most: Arqit Quantum (ARQQ) -58.0%, D-Wave Quantum (QBTS) -62.5%. Over five years, D-Wave Quantum (QBTS) compounded fastest (Arqit Quantum (ARQQ) -47.6%/yr, D-Wave Quantum (QBTS) +3.6%/yr). Returns are price only, before dividends.

Which stock is riskier?

By one-year price volatility, D-Wave Quantum (QBTS) has been the steadiest (Arqit Quantum (ARQQ) 111.5%, D-Wave Quantum (QBTS) 101.1%). Volatility measures how widely the price swings, not the risk of the business.

Do ARQQ and QBTS move together?

Their daily returns over the past year have a correlation of 0.67, a moderate positive relationship. Holding both diversifies more than two closely linked stocks would.

Which is the better stock, ARQQ and QBTS?

There is no single answer; it depends on what you are buying for. On the 12 head-to-head measures on this page, D-Wave Quantum (QBTS) leads on 3. Business Quant does not give investment advice; use the comparison as a starting point for your own research.

Data from SEC filings, exchange prices and consensus estimates, via Business Quant. Percentile scores compare each company with its own peer group, so two companies' scores are each relative to different peers unless you rank against the whole market. Price returns exclude dividends. Nothing on this page is investment advice.